Market Tracker

11/21 6:05pm ET

Amgen Inc (NASDAQ:AMGN)

162.81
Data as of Nov 21
 +0.13 / +0.08%
Today’s Change
108.20
Today|||52-Week Range
165.58
+42.72%
Year-to-Date

Today’s Trading

Previous close162.68
Today’s open165.58
Day’s range161.43 - 165.58
Volume3,716,962
Average volume (3 months)3,998,557
Market cap$123.8B
Dividend yield1.50%
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+20.29%
Earnings growth (this year)+12.78%
Earnings growth (next 5 years)+9.35%
Revenue growth (last year)+8.61%
P/E ratio25.6
Price/Sales4.60
Price/Book5.56

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences Inc-0.01-0.01%
BIIBBiogen Idec Inc+4.45+1.49%
BAXBaxter International...+0.45+0.63%
XONIntrexon Corp-0.07-0.27%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateJanuary 26, 2015
EPS forecast (this quarter)$2.04
Annual revenue (last year)$18.7B
Annual profit (last year)$5.1B
Net profit margin27.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts